![]() |
|
|
Vol. 286, Issue 2, 607-610, August 1998
Laboratoire de Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, UMR 5578, CNRS-Faculté de Médecine, Lyon, Cedex 08, France
| |
Abstract |
|---|
|
|
|---|
We recently demonstrated that adipocyte lactate production depends on
alpha-1 adrenergic control and that adipocytes can
produce lactate even when insulin-stimulated glucose uptake is markedly impaired. This prompted us to investigate the glucose uptake in response to an alpha-1 adrenergic stimulation. We
measured the adrenergic regulation of glucose uptake by adipocytes
isolated from epididymal white adipose tissue using agonists
(norepinephrine, phenylephrine and isoproterenol) and antagonists
(prazosin and propranolol) of alpha-1 and
beta adrenoceptor subtypes. Our results show that the
maximal glucose uptake obtained in the presence of
10
M norepinephrine is partially inhibited
by prazosin (10
M, 57%) or propranolol
(10
M, 52%) suggesting that glucose uptake
is subjected to both alpha-1 and beta
regulation. Indeed, our findings show that glucose uptake is
dose-dependently increased by phenylephrine. This stimulation is
totally inhibited by prazosin (10
M).
Isoproterenol stimulated glucose uptake. The stimulation of glucose
uptake by isoproterenol is totally inhibited in the presence of
propranolol (10
M) in the incubation medium.
Our results demonstrate for the first time that alpha-1
adrenergic subtype is involved in the regulation of glucose uptake by
white adipocytes.
| |
Introduction |
|---|
|
|
|---|
The
adrenergic stimulation of glucose uptake by white adipose cells has
been described both in vitro and in vivo in
previous studies. Ludvigsen et al. (1980)
reported that
epinephrine stimulated glucose uptake by isolated white adipocytes.
More recently, Liu et al. (1994)
showed a stimulated glucose
uptake in epididymal adipose tissue in rats perfused with increasing
doses of norepinephrine. Nevertheless, these results have drawn little
attention to characterization of the adrenergic stimulation of glucose
uptake into the alpha or beta effect. Ludvigsen
et al. (1980)
, using the 3-O-methyl glucose transport,
suggested that the effect of epinephrine was mediated in large part by
beta receptors and that there may be a small
alpha component of the stimulation by epinephrine.
Furthermore, Kashiwagi and Foley (1982)
showed that glucose uptake was
under beta adrenergic control in human isolated adipocytes.
Recent studies by our group have brought new insights on the role of
alpha-1 adrenoceptor in adipocyte metabolism. Indeed, we
recently demonstrated that rat adipocytes can produce lactate independent of lipolysis in insulin-resistant rats (Faintrenie and
Géloën, 1996a
) and that lactate production depends on
alpha-1 adrenergic control (Faintrenie and
Géloën, 1996b
). These experimental conditions raised the
question of the origin of lactate produced by insulin-resistant adipose
cells in which insulin hardly stimulates glucose uptake. This prompted
us to study glucose uptake in response to alpha-1 adrenergic
stimulation.
We studied the adrenergic regulation of glucose uptake in white
adipocytes from rat using agonists (norepinephrine, phenylephrine and
isoproterenol) and antagonists (prazosin and propranolol) of
alpha-1 and beta adrenoceptor subtypes. Our
results show that norepinephrine significantly stimulates glucose
uptake only at 10
8 M. Phenylephrine
increases glucose uptake dose-dependently, whereas isoproterenol
induces a maximal augmentation at 10
10 M;
beyond this dose, glucose uptake decreases but remains significantly higher than basal glucose uptake. Maximal glucose uptakes obtained in
the presence of phenylephrine (10
7 M) and
isoproterenol (10
10 M) are totally
inhibited, respectively, in the presence of prazosin (10
6 M) and propranolol
(10
6 M). These results demonstrate for the
first time a significant role of alpha-1 adrenoceptors in
the stimulation of glucose uptake by white adipose cells.
| |
Materials and Methods |
|---|
|
|
|---|
Male Sprague-Dawley rats (Iffa-Credo, l'Arbresle, France) weighing 300 to 350 g were kept on a 12:12 hr light/dark cycle (lights on 7:00 a.m. to 7:00 p.m.) and fed a standard laboratory chow diet (UAR A03, Villemoisson, France) and water ad libitum. On the day of the experiment, fed rats were rapidly killed by a sharp blow on the head followed by cervical dislocation.
Isolation of adipocytes. Adipocytes were isolated from 2.0 g of epididymal fat by a modification of Rodbell's original procedure (1964). Adipose tissues were weighed, minced and digested in a 20-ml polyethylene vial containing 8 ml of KRB buffer with 1 mg/ml collagenase (type 2, Clostridium histolyticum), 1% BSA (fraction 5, fatty acid free) and 200 nM adenosine. The vial was shaken at 80 cycles/min at 37°C. The resulting cell suspension was filtered through a nylon mesh (200 µm) and washed three times with 5 ml of fresh KRB buffer and 1% BSA and two times with the same buffer containing 4% BSA. Then, adipocytes were resuspended in KRB buffer and 4% BSA. A sample of the final cellular suspension was counted in a hemocytometer after staining with trypan blue.
Glucose transport assays. The uptake of 2-deoxyglucose by white adipocytes was measured by filtration assay. An aliquot of 300000 cells was preincubated in polyethylene vials containing fresh KRB buffer and 4% BSA with or without different concentrations of adrenergic agonists or antagonists (i.e., norepinephrine, isoproterenol, phenylephrine, prazosin or propranolol). The final volume was 1 ml. Adipocytes were incubated with gentle shaking (50 cycles/min) at 37°C for 30 min. KRB buffer (30 µl) containing 0.2 µCi of 2-[1,2-3H]deoxyglucose (CEA SA; Gif sur Yvette, France, 17 Ci/mmol) and 0.02 µCi of [14C]saccharose (Dositek SA, Orsay, France, 13.4 GBq/mmol) was then rapidly added. After 3 min of incubation, the flux of glucose was stopped by the addition of 5 ml of cold KRB buffer.
The cell suspension was immediately filtered onto a cellulose nitrate filter (8 µm, Sartorius), held by a filtration apparatus (Millipore). The filters were immediately washed with 5 ml and then 2.5 ml of cold KRB solution. The filters were put into scintillation vials and digested in 5 ml of Filter count (Packard) for 15 min with a shaking frequency of 150 cycles/min. The vial contents were then counted using a scintillation counter (Kontron SL 3000 Intertechnic). All the experiments were performed in triplicate.Statistical analysis. Results are presented as mean ± S.E.M. Statistical significance was tested with a analysis of variance (ANOVA) followed by Fisher's protected least significant difference test. Differences between mean values were accepted as significant at P < .05.
| |
Results |
|---|
|
|
|---|
Effects of norepinephrine on glucose-uptake by white
adipocytes.
Norepinephrine significantly increased glucose uptake
only at 10
8 M compared with basal glucose
uptake (1.86 ± 0.13 vs. 0.38 ± 0.02 nmol
2DG/300000 cell at 3 min, respectively; P < .05, fig. 1A). Beyond this concentration, glucose
uptake returned to basal values.
|
6 M), a beta
adrenergic antagonist, partially inhibited glucose uptake to 52% of
the maximal (i.e., 10
8 M
norepinephrine-stimulated) glucose uptake (0.77 ± 0.02 vs. 1.49 ± 0.10 nmol 2DG/300000 cell at 3 min for
norepinephrine + propranolol-stimulated glucose uptake and
norepinephrine-stimulated glucose uptake; P < .05). Prazosin, an
alpha-1 adrenergic antagonist, inhibited glucose uptake to
57% of norepinephrine-stimulated glucose uptake (0.85 ± 0.04 vs. 1.49 ± 0.10 nmol 2DG/300000 cell at 3 min,
respectively; fig. 1B).
Effects of isoproterenol on glucose-uptake by white
adipocytes.
Isoproterenol, a beta adrenergic agonist,
significantly increased glucose uptake compared with basal values.
Maximal glucose uptake was obtained in the presence of
10
10 M isoproterenol (1.49 ± 0.12 nmol 2DG/300000 cell at 3 min). Beyond this maximal response, the
glucose uptake decreased to ~50% of the maximal response but
remained significantly different than basal glucose uptake (0.84 ± 0.04, 0.72 ± 0.04 and 0.69 ± 0.04 nmol 2DG/300000 cell
at 3 min for 10
9,
10
8 and 10
7 M
isoproterenol vs. 0.43 ± 0.02 for basal glucose
uptake; P < .05, fig. 2A).
|
6 M had no effect on maximal
isoproterenol-stimulated glucose uptake [i.e., in the
presence of 10
10 M isoproterenol;
1.37 ± 0.18 vs. 1.44 ± 0.19 nmol 2DG/300000 cell
at 3 min for prazosin + isoproterenol
(10
10 M) and isoproterenol
(10
10 M), P = N.S.]. On the other
hand, glucose uptake measured in response to isoproterenol
(10
10 M) + propranolol
(10
6 M) was not significantly different
from glucose uptake obtained under basal conditions (0.45 ± 0.03 vs. 0.44 ± 0.02 nmol 2DG/300000 cell at 3 min,
respectively; P = N.S.). These results show that propranolol
totally inhibit the effect of 10
10 M
isoproterenol (fig. 2B).
Effects of phenylephrine on glucose uptake by white
adipocytes.
Glucose uptake increased dose-dependently with
phenylephrine concentrations (fig. 3A).
The highest dose of phenylephrine, an alpha-1 adrenergic
agonist, at a maximal dose (10
7 M) induced
a 2.5-fold increase of basal glucose uptake in epididymal adipocytes
(1.09 ± 0.03 vs. 0.44 ± 0.03 nmol 2DG/300000
cell at 3 min, respectively; P < .05).
|
7 M) was totally inhibited by
10
6 M prazosin. Indeed, in the presence of
prazosin, glucose uptake returned to basal values (0.55 ± 0.03 vs. 0.44 ± 0.02 nmol 2DG/300000 cell at 3 min,
respectively; P = N.S.). However, propranolol had no effect on
phenylephrine-stimulated glucose uptake [1.11 ± 0.03 vs. 1.01 ± 0.03 nmol 2DG/300000 cell at 3 min
for phenylephrine + propranolol- and phenylephrine
(10
7 M)-stimulated glucose uptake; P = N.S., fig. 3B].
| |
Discussion |
|---|
|
|
|---|
The main result of the present study is that phenylephrine
dose-dependently stimulates glucose uptake (fig. 3A). The effects of
phenylephrine were totally inhibited by
10
6 M prazosin (fig. 3B), whereas
propranolol had no effect on phenylephrine-induced glucose uptake.
These findings show undoubtedly that the specific stimulation of
alpha-1 adrenergic receptors results in the stimulation of
glucose uptake on epididymal adipocytes.
In the present study, norepinephrine and isoproterenol dose-response
curves are biphasic (figs. 1A and 2A), confirming the stimulatory
effect of low concentrations of catecholamines (Ludvigsen et
al., 1980
; Kashiwagi and Foley, 1982
) and the inhibitory effect of
high concentrations of catecholamines (Taylor et al., 1976
) on glucose uptake. Such a biphasic shape has been reported in vitro for the dose-response curves of glucose uptake by brown adipocytes in the presence of norepinephrine (Marette and Bukowiecki, 1989
) and in vivo for glucose uptake by epididymal white
adipose tissue (Liu et al., 1994
).
It is not easy to explain why the stimulation at the highest
concentrations of norepinephrine does not stimulate glucose uptake. One
explanation could be the elevation of intracellular cAMP concentration. Indeed, several studies have shown that cAMP inhibits glucose transport
in adipocytes (Taylor et al., 1976
; Kashiwagi and Foley, 1982
). An inverse correlation between rates of glucose transport and
intracellular cAMP concentration has been reported (Taylor and
Halperin, 1979
). It is of interest to note that norepinephrine and
isoproterenol stimulate glucose uptake at concentrations
(10
8 M for norepinephrine and
10
10 M for isoproterenol) at which
lipolysis is not at its maximal value (Faintrenie and
Géloën, 1996a
, 1996b
), suggesting that intracellular cAMP
could be not significantly increased.
Alpha-1 adrenoceptors are not linked to the adenylate
cyclase system and do not increase intracellular cAMP concentration. This may explain why glucose uptake is dose-dependently stimulated in
response to phenylephrine. The binding of alpha-1 agonists activates phospholipase C, which releases inositol-1,4,5-phosphate to
the cytosol, leaving diacylglycerol within the membrane. The primary
function of inositol-1,4,5-phosphate is to mobilize calcium from
intracellular stores (Berridge, 1987
). It has been suggested that
inositol-1,4,5-phosphate acts by opening the calcium channel (Smith
et al., 1985
) through the binding to a specific receptor that may be connected to a calcium channel of the endoplasmic reticulum.
In conclusion, our results show for the first time that a significant part of norepinephrine-glucose uptake is mediated through activation of alpha-1 adrenergic receptors. The study of possible modifications of the expression and activity of alpha-1 adrenergic receptors during the establishment of insulin resistance is needed to determine the role of these receptor subtypes in the onset of obesity and non-insulin-dependent diabetes.
| |
Footnotes |
|---|
Accepted for publication April 9, 1998.
Received for publication January 6, 1998.
1 G.F. was supported by a grant from Ministère de la Recherche et des Techniques. The authors wish to acknowledge financial support from Région Rhône-Alpes.
Send reprint requests to: Alain Géloën, Ph.D., Laboratoire de Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, UMR 5578, CNRS-Faculté de Médecine, Lyon Nord, 8 Avenue Rockefeller, 69373 Lyon, Cedex 08, France.
| |
Abbreviations |
|---|
KRB buffer, Krebs-Ringer bicarbonate buffer (25 mM HEPES and 6 mM glucose, pH 7.4; BSA, bovine serum albumin; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. S. Hutchinson and T. Bengtsson {alpha}1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol-3 Kinase-, and Atypical Protein Kinase C-Dependent Pathway Endocrinology, February 1, 2005; 146(2): 901 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chernogubova, B. Cannon, and T. Bengtsson Norepinephrine Increases Glucose Transport in Brown Adipocytes via {beta}3-Adrenoceptors through a cAMP, PKA, and PI3-Kinase-Dependent Pathway Stimulating Conventional and Novel PKCs Endocrinology, January 1, 2004; 145(1): 269 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Mick, X. Wang, and K. McCormick White Adipocyte Vascular Endothelial Growth Factor: Regulation by Insulin Endocrinology, March 1, 2002; 143(3): 948 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Salvi {alpha}1-Adrenergic Hypothesis for Pulmonary Hypertension Chest, June 1, 1999; 115(6): 1708 - 1719. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||